ISP passes on ingredient price hikes to drugmakers

Better alert purchasing because drug ingredient prices are going up, up, up again. All of its biocide products--especially those containing 3-Iodo-Propynyl-Butylcarbamate--are subject to a 10 percent price hike in June, says International Specialty Products of Wayne, NJ. The cost increase comes on top of one made in March.

ISP cites raw material cost escalation, especially for iodine, along with increasing regulatory, compliance, energy and transportation costs as co-conspirators.

Separately, ISP announced a 10 percent across-the-board boost for polymer, vinyl monomer, emollient, emulsifier, preservative and encapsulates prices. This increase follows a 10 percent bump in February. Then as now, material and energy cost escalation is the culprit.

Just two weeks ago, contract manufacturer Lonza cited rising raw material prices as having an impact on its first-half financial performance.

- here's the biocides announcement
- see the polymers release
- see the Lonza story


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.